Informação sobre produto
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-,[6R-[6a,7b(E)]]-
- Ro 15-2254
Ceftriaxone sodium impurity A is a pharmaceutical preparation that belongs to the class of macrolides. It is bacteriostatic and has been used to treat bacterial infections, including gonorrhea, urogenital and neisseria gonorrhoeae. Ceftriaxone sodium impurity A has been shown to have bacteriostatic activity in vitro, which may be due to its ability to bind to bacterial 16S ribosomal RNA or interfere with protein synthesis.